Franklin Resources, Inc. 13D and 13G filings for Marinus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-11 11:08 am Sale |
2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
FRANKLIN RESOURCES INC BEN |
0 0.000% |
-4,713,014 (Position Closed) |
Filing |
| 2024-10-31 1:05 pm Purchase |
2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
FRANKLIN RESOURCES INC BEN |
4,713,014 8.600% |
879,059 (+22.93%) |
Filing |
| 2024-02-06 11:58 am Purchase |
2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
FRANKLIN RESOURCES INC BEN |
3,833,955 7.000% |
3,833,955 (New Position) |
Filing |